Expansion of the Research Centre for Cytostatic Drugs (Q12109): Difference between revisions
Jump to navigation
Jump to search
(Changed label, description and/or aliases in 2 languages: Changing unique label-description pair) |
(Removed claim: financed by (P890): Directorate-General for Regional and Urban Policy (Q8361), Removing unnecessary financed by statement) |
||
| Property / financed by | |||
| Property / financed by: Directorate-General for Regional and Urban Policy / rank | |||
Revision as of 17:03, 28 October 2020
Project Q12109 in Czech Republic
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Expansion of the Research Centre for Cytostatic Drugs |
Project Q12109 in Czech Republic |
Statements
5,007,500.0 Czech koruna
0 references
10,015,000.0 Czech koruna
0 references
50 percent
0 references
30 June 2020
0 references
VUAB Pharma a.s.
0 references
50°9'46.91"N, 14°23'2.26"E
0 references
25263
0 references
Předkládaný projekt je zaměřen na rozšíření výzkumně-vývojového centra pro urychlení a zkvalitnění vývoje konečné lékové formy léčiv nádorových onemocnění, a to jak originálních, tak generických léčiv, které bylo vybudováno v předchozích letech. a. (Czech)
0 references
The submitted project is aimed at expanding the research-development centre for speeding up and improving the development of the final drug form of cancer drugs, both original and generic drugs that were built in previous years. a. (English)
22 October 2020
0 references
Identifiers
CZ.01.1.02/0.0/0.0/17_165/0015953
0 references